Showing 1 - 6 results of 6 for search 'Charles F. Gilks', query time: 0.01s Refine Results
  1. 1
    To what extent is equity entrenched in HIV/AIDS-related policy documents in Ethiopia? A policy content analysis

    To what extent is equity entrenched in HIV/AIDS-related policy documents in Ethiopia? A policy content analysis by Aklilu Endalamaw, Charles F. Gilks, Yibeltal Assefa

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Socioeconomic inequality and contributors in accepting attitudes toward people living with HIV among adults in Ethiopia from 2005 to 2016: a population-based cross-sectional study

    Socioeconomic inequality and contributors in accepting attitudes toward people living with HIV among adults in Ethiopia from 2005 to 2016: a population-based cross-sectional study by Yibeltal Assefa, Charles F Gilks, Fentie Ambaw, Aklilu Endalamaw

    Published 2023-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.

    High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the... by Cissy Kityo, Diana M Gibb, Charles F Gilks, Ruth L Goodall, Ivan Mambule, Pontiano Kaleebu, Deenan Pillay, Ronnie Kasirye, Peter Mugyenyi, A Sarah Walker, David T Dunn, DART Trial Team

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.

    Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial. by Katherine A Sutherland, Chris M Parry, Adele McCormick, Anne Kapaata, Fred Lyagoba, Pontiano Kaleebu, Charles F Gilks, Ruth Goodall, Moira Spyer, Cissy Kityo, Deenan Pillay, Ravindra K Gupta, DART Virology Group

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.

    Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial. by Diana M Gibb, Hilda Kizito, Elizabeth C Russell, Ennie Chidziva, Eva Zalwango, Ruth Nalumenya, Moira Spyer, Dinah Tumukunde, Kusum Nathoo, Paula Munderi, Hope Kyomugisha, James Hakim, Heiner Grosskurth, Charles F Gilks, A Sarah Walker, Phillipa Musoke, DART trial team

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.

    Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe. by Antonieta Medina Lara, Jesse Kigozi, Jovita Amurwon, Lazarus Muchabaiwa, Barbara Nyanzi Wakaholi, Ruben E Mujica Mota, A Sarah Walker, Ronnie Kasirye, Francis Ssali, Andrew Reid, Heiner Grosskurth, Abdel G Babiker, Cissy Kityo, Elly Katabira, Paula Munderi, Peter Mugyenyi, James Hakim, Janet Darbyshire, Diana M Gibb, Charles F Gilks, DART Trial Team

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: